The drug Invokana, approved by the FDA in March 2012, is classified as an SGLT2 inhibitor, which works by reducing blood sugar levels in Type 2 diabetes patients. Invokana has been linked to a number of serious kidney problems, including ketoacidosis, a serious buildup of acids in the blood that can be life threatening if left untreated. Current Invokana lawsuits being filed claim the manufacturers failed to warn patients and physicians of the increased risks of kidney failure, ketoacidosis, and leg and foot amputations. The Dugan law Firm is accepting clients who took Invokana and suffered injuries.
Thousands of claims have been filed against Johnson & Johnson and Janssen Pharmaceuticals by individuals who have suffered injuries as a result of taking Invokana. The lawsuits are presently combined before a federal judge in New Jersey, where all of the national discovery and evidence gathering is taking place. Invokana has been linked to kidney damage, ketoacidosis and amputations.
The most serious potential side effects and risks caused by Invokana include:
- Kidney Damage
- Heart Attack